 |
|
Feasibility of Non-TBI Conditioning with Busulfan and Fludarabine for Allogeneic Stem Cell Transplantation in Lymphoid Malignancy
Ho Cheol Shin, Yoo Jin Lee, Joon Ho Joon Ho, Soo Jung Lee, Byung Woog Kang, Yee Soo Chae, Jong Gwang Kim, Jun Young Choi, Jong Won Seo, Yu Kyung Kim, Jang Soo Suh, Sang Kyun Sohn
Korean J Intern Med. 2012;27(1):72-83. Published online 2012 Feb 28 DOI: https://doi.org/10.3904/kjim.2012.27.1.72
|
|
Citations to this article as recorded by
 Prognostic factors and treatment outcomes of allogeneic stem cell transplantation in lymphoid malignancy
Hyungsoon Kim, Haerim Chung, Hye Won Kook, Soo-Jeong Kim, Yu Ri Kim, Hyunsoo Cho, June-Won Cheong
Blood Research.2025;[Epub] CrossRef Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis
S Ben-Barouch, O Cohen, L Vidal, I Avivi, R Ram
Bone Marrow Transplantation.2016; 51(2): 232. CrossRef
|